Applications in the prescribed format has been invited by TMC-ACTREC for online examination and the award of JUNIOR RESEARCH FELLOWSHIPS [JRF 2024] for Ph.D. in Life Sciences at TMC-ACTREC.
The prescribed format for application is available on ACTREC website https://actrec.gov.in
Deadline for Online Application: Date: 15th dec.,2023
Qualifications: M.Sc./ M. Tech (Applied Biology / Biochemistry / Bioinformatics / Biophysics / Biotechnology / Botany / Life Sciences / Microbiology/ Molecular Biology / Zoology or related Biological Sciences), M.V.Sc. and M.Pharm from a recognized University, with ³ 55% aggregate marks. Those awaiting results may also apply. As per HBNI guidelines, candidates with < 55% aggregate marks cannot be considered for an interview or admission to the program. Candidates who have done post-graduation course of only ONE year duration are not eligible. Final admission into the Ph.D. program is subject to the candidate satisfying HBNI eligibility criteria as mentioned above. TMC reserves the right to increase the minimum eligibility criteria in case of receipt of large number of applications.
Stipend: Junior Research Fellowship (JRF) of Rs. 31000/+ 27% HRA per month (HRA is only applicable if hostel facility is not opted), which gets converted into SRF based on fellow’s performance in the 3rd year. Limited hostel facility is available on a first come, first served basis for the new entrants for a period of one year. Ph.D. scholars are also entitled to avail the In-house medical facility and local transport services.
Application Procedure: Candidates are advised to carefully read the instructions before filling the online application [https://actrec.gov.in]. Forms submitted with incomplete information, without application fees (wherever payable) or required document upload will be rejected. Application fees should be paid online; the fees for male candidates is Rs 750/- and for female candidates is Rs 500/-, while SC/ ST/ OBC (caste proof should be attached) and physically handicapped candidates with minimum 40% disability (disability proof must be attached) are fully exempted from paying fees. Application fees paid online are non-refundable. The online application deadline is December 15, 2023.
Online Examination: A list of eligible candidates for the Online Objective Entrance Exam will be displayed in the last week of December ‘23 on the ACTREC website. The Online Exam will be conducted on January 06, 2024 from 9 AM – 12 noon in 10 Examination Centres located in Bangalore, Chennai, Delhi NCR, Guwahati, Hyderabad, Indore, Kolkata, Mumbai, Pune, and Varanasi (centre allotment details will be uploaded on the ACTREC website ahead of the exam date). Students have to give 3 choices of Exam Centre in their application. In case the number of students opting for a centre is below 75, the students opting for that centre will be accommodated at either their second or third choice of centre.
Eligibility for Direct Interview (Online application for ACTREC JRF2024 is mandatory)
- Candidates holding valid Junior Research Fellowships awarded after qualifying a national level written entrance test conducted by CSIR/ UGC/ ICMR/ DBT or other recognized agencies.
- Candidates who receive external fellowship intimation by April 15, 2024 must send their proof of the award by e-mail [[email protected]] to seek direct interview dates.
- Qualified Joint Graduate Entrance Examination for Biology and Interdisciplinary Life Sciences (JGEEBILS) candidates who are eligible for ACTREC Ph.D. program will be shortlisted and displayed on the ACTREC website in due course of time.
JRF Interview Dates: The list of candidates qualifying for interview based on the ACTREC online exam results or eligible for direct interview will be displayed on our website in April, 2024. Interviews of candidates who have cleared the ACTREC entrance test as well as those eligible for direct Interviews will be conducted between May and June 2024 – the exact dates will be displayed on the ACTREC website.
Research Projects: The list of JRF projects being offered to Ph.D. students at ACTREC will be displayed on the ACTREC website in due course of time.
Declaration of the Results: The list of candidates to be called for interviews will be displayed on the ACTREC website.
Detailed Advertisement Link: https://actrec.gov.in/sites/default/files/JRF2024-Advertisement.pdf
About TMC – ACTREC
The Advanced Centre for Treatment, Research and Education in Cancer (ACTREC) is the state of art of R&D wing of the Tata Memorial Centre.
It is located in the picturesque settings at the foothills of the Sahyadri mountains in Kharghar, Navi Mumbai. ACTREC comprises of, the Cancer Research Institute (CRI), Clinical Research Centre (CRC) and Centre for Cancer Epidemiology (CCE), a setting that is unique in India and built and evolved with a vision to provide comprehensive cancer care to one and all, through its motto of excellence in services, education and research.
The three centers have specific agendas, focus and unique capabilities. They work independently and in collaboration towards a common goal i.e., to advance research on all aspects of cancer, improve diagnosis, predict prognosis and treatment outcome of cancer patients, prolong their survival and ultimately cure cancer!
Cancer Research Institute (CRI): Scientists in CRI undertake multi-pronged investigations into cancer biology, which address basic and translational research queries using human tumors, experimental animals and cells in culture, with an aim to provide the tools for chemoprevention, early diagnosis, prognosis and therapy. Commensurate with these goals the research projects at CRI encompass the following thematic – Biomolecular Structure, Function and alteration; Cell and Tumor Biology; Carcinogenesis, Genome Biology and Precision Medicine; Therapy Resistance and Stem Cell Biology; Tumor Immunology and Immunotherapy; Cancer Theranostics and Clinical Pharmacology.
Clinical Research Centre (CRC): CRC and Hospital are integral, vital constituents of ACTREC that are making considerable headway into clinical research while focusing on advanced modes of cancer therapy. In keeping with the overall mandate of the ACTREC, the CRC is focusing initially on pediatric cancers, brain tumours, head and neck cancer, cervical cancer, breast cancer, cancer genetics and technology evaluation.
Centre for Cancer Epidemiology (CCE): The Centre for Cancer Epidemiology is commissioned with a focus to assess and evaluate the cancer burden in the country.
Funding: The clinicians, clinician scientists and basic scientists of the Centre are engaged in a large number of clinical trials and audits, as well as institutional, intramural and extramural projects. The trials involve collaborations between the Centre and industry particularly the Pharma sector. Funding support for most projects come from either the Centre itself or from governmental funding agencies such as DST, DBT, ICMR, etc. While some of the studies are stand alone, the vast majorities are collaborative projects involving close interaction between scientists and/or clinicians within and outside the Centre; some are multicentric international projects
Education: ACTREC continues its emphasis and focus on its academic programs, prime amongst which is the Doctoral program. The Ph.D. programs under Life Sciences and Health Sciences are affiliated to the Homi Bhabha National Institute – a deemed university recognized by the University Grants Commission.
CRC has an important mandate of development of a structured post-doctoral educational programme in every clinical discipline of oncology. This includes Medical and Paediatric Oncology, Cancer Genetics, Bone Marrow and Stem Cell Transplant, Neuro-Oncology, Radiation Biology, High Precision Radiotherapy, Brachytherapy, Paediatric Surgical Oncology, and Clinical Research Methodology. The Homi Bhabha National Institute (a deemed university) is a first step in that direction, which would enable the education programme to take root successfully.
Future: Several new projects are on the verge of completion within ACTREC. These will transform ACTREC in the near future into a very large and niche cancer hospital with about 900 beds. The projects are technologically and thematically complex including a Proton Beam Therapy Centre, a Centre to treat children’s and hematological cancers, a Centre to treat solid tumors and an advanced centre for nuclear medicine.
(Source: https://actrec.gov.in)
